S

Swedencare AB (publ)
OTC:SWDCF

Watchlist Manager
Swedencare AB (publ)
OTC:SWDCF
Watchlist
Price: 3.87 USD Market Closed
Market Cap: 614.3m USD
Section:
 

Relative Value

The Relative Value of one SWDCF stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.87 USD, Swedencare AB (publ) is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SWDCF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
88
vs Industry
46
Median 3Y
2.9
Median 5Y
3.7
Industry
2.6
Forward
2.2
More Details
98.1
P/E
P/E
Price to Earnings
98.1
vs History
63
vs Industry
6
Median 3Y
97.4
Median 5Y
131.4
Industry
21.4
Forward
55.3
More Details
17
P/OCF
P/OCF
Price to OCF
17
vs History
76
vs Industry
25
Median 3Y
18.6
Median 5Y
21.9
Industry
16.4
More Details
19.1
P/FCFE
P/FCFE
Price to FCFE
19.1
vs History
52
vs Industry
16
Median 3Y
19
Median 5Y
19.6
Industry
22.8
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
65
vs Industry
66
Median 3Y
0.9
Median 5Y
1
Industry
2.2
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
87
vs Industry
39
Median 3Y
3.5
Median 5Y
4.4
Industry
2.9
Forward
2.8
More Details
8.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.6
vs History
63
vs Industry
27
Median 3Y
8.5
Median 5Y
9.5
Industry
5.5
More Details
16
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16
vs History
76
vs Industry
27
Median 3Y
16.6
Median 5Y
21.2
Industry
13
Forward
14.2
More Details
45.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.1
vs History
71
vs Industry
13
Median 3Y
47.9
Median 5Y
63.6
Industry
16.5
Forward
26.9
More Details
21.2
EV/OCF
EV/OCF
Enterprise Value to OCF
21.2
vs History
76
vs Industry
21
Median 3Y
22.7
Median 5Y
25.7
Industry
15.6
More Details
24.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.7
vs History
76
vs Industry
19
Median 3Y
27
Median 5Y
30.6
Industry
18.7
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
66
vs Industry
67
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9
More Details

Multiples Across Competitors

SWDCF Competitors Multiples
Swedencare AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Swedencare AB (publ)
OTC:SWDCF
6.2B USD 2.3 98.1 16 45.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
SE
S
Swedencare AB (publ)
OTC:SWDCF
Average P/E: 32.5
98.1
54%
1.8
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
S
Swedencare AB (publ)
OTC:SWDCF
Average EV/EBITDA: 401.2
16
16%
1
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
S
Swedencare AB (publ)
OTC:SWDCF
Average EV/EBIT: 1 716.2
45.1
36%
1.3
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5

See Also

Summary
SWDCF intrinsic value, competitors valuation, and company profile.
DCF Valuation
SWDCF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SWDCF stock valuation using valuation multiples.
Wall Street Estimates
SWDCF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SWDCF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.